Functionalization of Boron Dipyrrin Dyes
FULL PAPER
Crystallographic data collection and structure refinement: Data for 2 f
were collected at low temperature (À1538C) on a Rigaku RAXIS-
RAPID with graphite-monochromated MoKa radiation (l=0.71069 ꢂ),
and data for 2d and 3d at À1838C on a Bruker SMART APEX with
graphite-monochromated MoKa radiation (l=0.71069 ꢂ). Details of the
crystallographic data are listed in Table 2. The structures were solved by
direct methods (Sir 97[21] or SHELXS-97[22]) and full-matrix least-squares
techniques (SHELXL-97).[22] CCDC 709675 (2 f), 709674 (2d) and 709676
(3d) contain the supplementary crystallographic data for this paper.
These data can be obtained free of charge from the Cambridge Crystallo-
was performed by column chromatography on silica gel (THF/hexane=
1/10) and recrystallization (CH2Cl2/hexane) to give BODIPY 2c
(powder) in 29% yield and BODIPY 2d (powder) in 9% yield.
BODIPY 2c: 1H NMR (CD2Cl2): d=2.08 (s, 6H; CH3 in mesityl), 2.35
(s, 3H; CH3 in mesityl), 3.75 (s, 3H; OCH3), 6.11 (d, J=15.1 Hz, 1H;
double bond), 6.49 (m, 1H; pyrrole H), 6.62 (d, J=4.1 Hz, 1H; pyrrole
1H), 6.64 (d, J=4.5 Hz, 1H; pyrrole H), 6.85 (d, J=4.1 Hz, 1H; pyrrole
H), 6.97 (s, 2H; ArH), 7.10 (dd, J=15.5, 11.5 Hz, 1H; double bond), 7.42
(d, J=15.6 Hz, 1H; double bond), 7.52 (dd, J=15.1, 11.0 Hz, 1H; double
bond), 7.84 ppm (s, 1H; pyrrole H); MS (MALDI-TOF): m/z 420.94
[M+], calcd m/z 420.26 [M+]; UV/Vis (CH2Cl2): lmax (e)=566 nm (1.07ꢁ
105 MÀ1 cmÀ1).
BODIPY 2d: 1H NMR (CD2Cl2): d=2.09 (s, 6H; CH3 in mesityl), 2.36
(s, 3H; CH3 in mesityl), 3.76 (s, 6H; OCH3), 6.12 (d, J=15.1 Hz, 2H;
double bond), 6.59 (d, J=4.1 Hz, 2H; pyrrole H), 6.88 (d, J=4.6 Hz, 2H;
pyrrole 1H), 6.98 (s, 2H; ArH), 7.11 (dd, J=15.6, 11.5 Hz, 2H; double
bond), 7.44 (d, J=15.6 Hz, 1H; double bond), 7.55 ppm (dd, J=15.1,
11.5 Hz, 1H; double bond); MS (ESI-TOF): m/z 553.2088 [M+Na+],
calcd m/z 553.2086 [M+Na+]; UV/Vis (CH2Cl2): lmax (e)=641 nm (1.43ꢁ
105 mÀ1 cmÀ1).
General procedure for the synthesis of a-substituted BODIPY dyes:
meso-Mesityldipyrromethane (264 mg, 1.0 mmol, 1.0 equiv), bis(pinacola-
to)diboron (508 mg, 2.0 mmol, 2.0 equiv), 4,4’-di-tert-butyl-2,2’-bipyridyl
(5.4 mg, 0.02 mmol, 0.02 equiv), and [{IrACHTNUTRGENNUG(cod)ACHTUNGTREN(NUGN OMe)}2] (6.63 mg,
0.01 mmol, 0.01 equiv) were added to a Schlenk flask, which was evacuat-
ed and purged with argon five times, and then charged with dried 1,4-di-
oxane (3.0 mL). The mixture was stirred at reflux for 24 h under argon
(oil-bath temperature: 100–1058C). After removal of the solvents under
vacuum, the residue was dissolved in CH2Cl2. The solution was filtered
through a short pad of Florisil (ca. 1.5 cm high, eluent: CH2Cl2), which
was washed with CH2Cl2 to remove the catalyst and insoluble salts. The
solvent was removed and the residue dried in vacuum to give the crude
borylated compounds (508 mg, a colorless glassy solid) without separa-
tion. The borylated compound (258 mg, 0.5 mmol, 1.0 equiv) and the cat-
BODIPYs 2e and 2 f: The general procedure was followed, but ethyl ac-
rylate was used instead of hexyl acrylate. Final purification was per-
formed by column chromatography on silica gel (CH2Cl2/hexane=1:10)
to give BODIPY 2e (oil) in 13% yield and BODIPY 2 f (powder, recrys-
tallized from CH2Cl2/hexane) in 30% yield.
alyst [{RhACHTUNGTRENNUNG(cod)(OH)}2] (11.4 mg, 0.025 mmol, 0.05 equiv) were added to
BODIPY 2e: 1H NMR (CDCl3): d=1.36 (t, 3H; J=7.4 Hz, CH3 in
ethyl), 2.09 (s, 6H; CH3 in mesityl), 2.36 (s, 3H; CH3 in mesityl), 4.31 (q,
2H; J=7.3 Hz; OCH2 in ethyl), 6.51 (d, J=3.7 Hz, 1H; pyrrole H), 6.56
(d, J=16.1 Hz, 1H; double bond), 6.62 (d, J=4.6 Hz, 1H; pyrrole H),
6.69 (d, J=4.1 Hz, 1H; pyrrole H), 6.79 (d, J=4.5 Hz, 1H; pyrrole H),
6.96 (s, 2H; ArH), 7.95 (s, 1H; pyrrole H), 8.10 ppm (d, J=16.5 Hz, 1H;
double bond); MS (ESI-TOF): m/z 431.1705 [M+Na+], calcd m/z
431.1717 [M+Na+]; UV/Vis (CH2Cl2): lmax (e)=545 nm (9.16ꢁ
104 mÀ1 cmÀ1).
BODIPY 2 f: 1H NMR (CDCl3): d=1.38 (t, 6H; J=6.8 Hz, CH3 in
ethyl), 2.09 (s, 6H; CH3 in mesityl), 2.36 (s, 3H; CH3 in mesityl), 4.32 (q,
4H; J=7.3 Hz; OCH2 in hexyl), 6.59 (d, J=16.0 Hz, 2H; double bond),
6.63 (d, J=4.6 Hz, 2H; pyrrole H), 6.83 (d, J=4.6 Hz, 2H; pyrrole H),
6.96 (s, 2H; ArH), 8.13 ppm (d, J=16.0 Hz, 2H; double bond); MS (ESI-
TOF): m/z 529.2058 [M+Na+], calcd m/z 529.2086 [M+Na+]; UV/Vis
(CH2Cl2): lmax (e)=593 nm (1.25ꢁ105 mÀ1 cmÀ1).
a Schlenk flask, which was evacuated and purged with argon three times,
and then charged with dioxane (2.5 mL), H2O (250 mL), and hexyl acry-
late (365 mL, 2.0 mmol, 4.0 equiv). The mixture was stirred at reflux for
24 h under argon (oil-bath temperature: 100–1058C). After removal of
the solvent, the residue was dissolved in 5 mL of THF, and DDQ
(114 mg, 0.5 mmol, 1.0 equiv) was added to the solution. After stirring at
room temperature for 15 min, the reaction mixture was quenched with a
saturated aqueous solution of NaHCO3 and extracted with CH2Cl2. The
organic layer was washed with water and dried over Na2SO4. Solvents
were removed and the residue was dissolved in 5 mL of toluene. After
purging with argon for 15 min, triethylamine (0.8 mL, 5.0 mmol,
10 equiv) was added to the reaction mixture followed by BF3·OEt2
(0.8 mL, 5.0 mmol, 10 equiv). The mixture was stirred at room tempera-
ture for 30 min, quenched with a saturated aqueous solution of NaHCO3,
and extracted with CH2Cl2. The organic layer was washed with water and
dried over Na2SO4. Solvents were removed and the residue was filtered
through a short pad of silica gel (eluent: CH2Cl2) to remove insoluble
salts and polar byproducts. The mixture was purified by GPC (BioRad
Bio-Beads SX-1, packed in a 3.0ꢁ60 cm gravity-flow column; eluent:
THF) to afford four major bands (in order of elution): 1) unidentified by-
product, 2) a,a’-diacrylate BODIPY 2b (oil, 71 mg, 22% yield), 3) a-
monoacrylate BODIPY 2a (oil, 39 mg, 16% yield), and 4) unsubstituted
BODIPY 1.
BODIPY 2a: 1H NMR (CDCl3): d=0.91 (t, 3H; J=6.8 Hz, CH3 in
hexyl), 1.25–1.69 (m, 8H; CH2 in hexyl), 2.09 (s, 6H; CH3 in mesityl),
2.36 (s, 3H; CH3 in mesityl), 4.23 (t, 2H; J=6.8 Hz; OCH2 in hexyl), 6.51
(d, J=4.1 Hz, 1H; pyrrole H), 6.56 (d, J=16.0 Hz, 1H; double bond),
6.62 (d, J=4.6 Hz, 1H; pyrrole H), 6.69 (d, J=4.1 Hz, 1H; pyrrole H),
6.79 (d, J=4.1 Hz, 1H; pyrrole H), 6.96 (s, 2H; ArH), 7.95 (s, 1H; pyr-
role H), 8.10 ppm (d, J=16.5 Hz, 1H; double bond); MS (ESI-TOF):
m/z 487.2345 [M+Na+], calcd m/z 487.2344 [M+Na+]; UV/Vis (CH2Cl2):
lmax (e)=545 nm (8.74ꢁ104 mÀ1 cmÀ1).
General procedure for the synthesis of b-substituted BODIPY dyes:
meso-Mesityl BODIPY (1, 100 mg, 0.32 mmol, 1.0 equiv), bis(pinacola-
to)diboron (81.7 mg, 0.32 mmol, 1.0 equiv), 4,4’-di-tert-butyl-2,2’-bipyridyl
(4.3 mg, 0.016 mmol, 0.05 equiv), and [IrACHTNUGTRNEUNG(cod)OMe]2 (5.3 mg, 0.008 mmol,
0.025 equiv) were added to a Schlenk flask, which was evacuated and
purged with argon five times, and then charged with dried dioxane
(3.0 mL). The mixture was stirred at reflux for 16 h under argon. After
removal of the solvent under vacuum, the residue was dissolved in
CH2Cl2. The solution was passed through a short pad of Florisil (ca.
1.5 cm high, eluent: CH2Cl2) to remove the catalyst and insoluble salts.
Then the crude product was transferred to a 50 mL round-bottomed-flask
and the solvent removed under vacuum to give the borylated products.
[{RhACTHUNTRGNE(UGN cod)(OH)}2] (7.3 mg, 0.016 mmol, 0.05 equiv) was added to the
flask, which was then purged with argon and charged with hexyl acrylate
(226 mL, 1.29 mmol, 4 equiv), H2O (300 mL), and dioxane (3.0 mL). The
mixture was stirred at room temperature for 24 h under argon. The sol-
vent was evaporated under vacuum, and the crude product purified by
chromatography on silica gel (CH2Cl2/hexane=3/1) to provide BODIPY
3a (oil) in 7% yield and BODIPY 3b (powder) in 7% yield.
BODIPY 3a: 1H NMR (CDCl3): d=0.88 (t, J=6.8 Hz, 3H; CH3 in
hexyl), 1.25–1.65 (m, 8H; CH2 in hexyl), 2.10 (s, 6H; CH3 in mesityl),
2.38 (s, 3H; CH3 in mesityl), 4.14 (t, J=6.8 Hz, 2H; OCH2 in hexyl), 6.17
(d, J=16.0 Hz, 1H; double bond), 6.54 (d, J=3.7 Hz, 1H; pyrrole H),
6.73 (s, 1H; pyrrole H), 6.77 (d, J=4.1 Hz, 1H; pyrrole H), 6.97 (s, 2H;
ArH), 7.47 (d, J=16.0 Hz, 1H; double bond), 8.00 (s, 1H; pyrrole H),
8.03 ppm (s, 1H; pyrrole H); MS (ESI-TOF): m/z 487.2338 [M+Na+],
BODIPY 2b: 1H NMR (CDCl3): d=0.91 (t, 6H; J=6.8 Hz, CH3 in
hexyl), 1.25–1.74 (m, 16H; CH2 in hexyl), 2.09 (s, 6H; CH3 in mesityl),
2.36 (s, 3H; CH3 in mesityl), 4.26 (t, 4H; J=6.9 Hz; OCH2 in hexyl), 6.59
(d, J=16.0 Hz, 2H; double bond), 6.63 (d, J=4.1 Hz, 2H; pyrrole H),
6.83 (d, J=4.6 Hz, 2H; pyrrole H), 6.96 (s, 2H; ArH), 8.14 (d, J=
16.0 Hz, 2H; double bond); MS (ESI-TOF): m/z 641.3316 [M+Na+],
calcd m/z 641.3339 [M+Na+]; UV/Vis (CH2Cl2): lmax (e)=593 nm (9.27ꢁ
104 mÀ1 cmÀ1).
BODIPYs 2c and 2d: The general procedure was followed, but methyl
2,4-pentadienoate was used instead of hexyl acrylate. Final purification
Chem. Eur. J. 2009, 15, 5942 – 5949
ꢀ 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
5947